New drug HRS9531 aims to prevent heart attacks in 9,000+ patients
NCT ID NCT07551492
First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study tests if a new medicine, HRS9531, can lower the chance of major heart problems like heart attacks and strokes in people with hardened arteries. About 9,262 adults with heart disease will receive either the drug or a placebo. The goal is to see if the drug helps control the disease and prevent future events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, CAMS&PUMC
Beijing, Beijing Municipality, 100037, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.